Anna Eshoo actually said...
So if FDA had a similar authority for a conditional approval pathway, would that give the FDA more flexibility in getting potentially promising therapies to dying patients sooner?
Context
Eshoo questions the FDA's ability to expedite drug approvals for critical patients.
07/28/2021